Q4 2023
Released Feb 15, 2024, after the close
10-K filed Feb 15, 2024, 46 days after period end · 0000950170-24-015920
Q4 2023 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income-$2.06M-$2.06M derivedno prior Q4 2022 on fileN/M vs Q3 2023
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$2,490,104—
Operating Cash Flowderived-$499,060—
Free Cash Flowderived-$499,038—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2023dderived from reported figures | Q4 2022 | Q4 2021 | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$2.06M | -$2.92M | -$3.39M | -$2.99M |
| EPS Diluted | — | -$0.06 | -$0.07 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medicinova Inc · CIK 1226616 · Engraved from SEC EDGAR